Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. November 2023 01:00 ET | Quelle: Repairon gmbh

BioVAT-HF Phase 1/2 Reveals First Evidence for Effective Heart Repair in Advanced Heart Failure

Featured Late Breaking Clinical Science presentation at American Heart Association Scientific Sessions in PhiladelphiaSafe Maximal Dose Confirmed with 12-month follow-upProof for vascularized...
15. September 2023 01:00 ET | Quelle: Repairon gmbh

Repairon Appoints Co-Founder Dr. Lothar Germeroth as Chief Executive Officer

GÖTTINGEN, Germany, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Repairon, a clinical-stage German biotech company focused on developing a novel reparative treatment for heart failure, today announced...
04. April 2023 08:00 ET | Quelle: Repairon gmbh

Repairon Announces Completion of Dose-Finding Part of BioVAT-HF Phase 1/2 Trial in Advanced Heart Failure

Feasibility and safety demonstrated in patients with advanced heart failureSafe maximal dose for continuation into Phase 2 (Proof-of-Concept) identifiedProof for successful heart remuscularization...